Related Experiment Video
Updated: Jul 12, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.0K
Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update
Rahul Seth1, Hans Messersmith2, Pauline Funchain3
1SUNY Upstate Medical University, Syracuse, NY.
Summary
ASCO Rapid Recommendations Updates provide timely revisions to cancer care guidelines based on new evidence. These updates ensure healthcare providers and patients receive the latest information for optimal cancer treatment decisions.
Area of Science:
- Oncology
- Clinical Practice Guidelines
- Evidence-Based Medicine
Background:
- Clinical practice guidelines require regular updates to reflect new scientific discoveries.
- Practice-changing data in oncology necessitates rapid dissemination of revised recommendations.
- The American Society of Clinical Oncology (ASCO) guideline development process ensures rigor and timeliness.
Purpose of the Study:
- To inform healthcare practitioners and the public about updated cancer care guidelines.
- To disseminate practice-changing data in oncology in a timely manner.
- To ensure cancer treatment recommendations align with the latest evidence.
Main Methods:
- ASCO Rapid Recommendations Updates are based on comprehensive evidence reviews.
- Updates follow established ASCO Guideline Methodology.
- New data triggers a review and potential revision of existing recommendations.
Main Results:
- Revisions to select ASCO guideline recommendations are published.
- Updated recommendations are made available to stakeholders.
- The process ensures the dissemination of current best practices in cancer care.
Conclusions:
- Rapid Updates are crucial for maintaining guideline relevance in oncology.
- Timely dissemination of evidence ensures optimal patient care.
- ASCO's commitment to guideline updates supports evidence-based cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.